AbbVie (ABBV) Pension (2012 - 2015)
AbbVie (ABBV) posted quarterly Pension of $1.9 billion for Q4 2015, down 12.21% year-over-year from $2.2 billion in Q4 2014, and down 12.21% quarter-over-quarter from $2.2 billion in Q4 2014.
AbbVie (ABBV) Pension (2012 - 2015) Analysis & Trends
AbbVie (ABBV) has reported Pension for 4 consecutive years, with $1.9 billion the latest figure, recorded in Q4 2015.
- In Q4 2015, Pension fell 12.21% year-over-year to $1.9 billion; the TTM figure through Dec 2015 stood at $1.9 billion (down 12.21% YoY), while the FY2015 annual figure was $1.9 billion, down 12.21% from the prior year.
- Pension slipped to $1.9 billion in Q4 2015 per ABBV's latest filing, from $2.2 billion in the prior quarter.
- Across five years, Pension topped out at $2.2 billion in Q4 2014 and bottomed at $979.0 million in Q4 2012.
- Historically, Pension has averaged $1.7 billion across 4 years, with a median of $1.8 billion in 2013.
- Annual changes were most pronounced in 2013 — Pension soared 66.29% — and 2015, when it slipped 12.21%.
- AbbVie's Pension stood at $979.0 million in 2012, then soared by 66.29% to $1.6 billion in 2013, then soared by 36.36% to $2.2 billion in 2014, then declined by 12.21% to $1.9 billion in 2015.
- Business Quant data shows ABBV's Pension at $1.9 billion in Q4 2015, $2.2 billion in Q4 2014, and $1.6 billion in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.95 Bn |
| Dec 31, 2014 | 2.22 Bn |
| Dec 31, 2013 | 1.63 Bn |
| Dec 31, 2012 | 979.00 Mn |